Reference health

Acidity, lipophilicity, solubility, absorption, and polar surface area of some ACE inhibitors

https://doi.org/10.2478/s11696-007-0010-y
CiteStamped reference-health badge
1 of 56 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

does not resolve to a known work10.1254/jjp.81.346
The 55 checked references that resolve
resolves10.1016/S0002-9149(99)80508-6
Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor
resolves10.2165/00003088-199019030-00003
Clinical Pharmacokinetics of the Newer ACE Inhibitors
resolves10.1002/jps.2600840120
Atom/Fragment Contribution Method for Estimating Octanol–Water Partition Coefficients
resolves10.1021/ci000392t
Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices
resolves10.1016/j.pcad.2004.04.003
The clinical use of angiotensin-converting enzyme inhibitors
resolves10.1021/jm049509l
Application of ALOGPS 2.1 to Predict log <i>D</i> Distribution Coefficient for Pfizer Proprietary Compounds
resolves10.1016/S1359-6446(05)03584-1
Computing chemistry on the web
resolves10.1021/jm000942e
Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties
resolves10.1016/0169-409X(95)00129-U
The intestinal peptide carrier: A potential transport system for small peptide derived drugs
resolves10.1016/S0021-9673(00)00591-4
Optimization of capillary electrophoretic separation of several inhibitors of the angiotensin-converting enzyme
resolves10.1016/j.bmc.2005.10.020
Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives
resolves10.1021/ci010368v
Prediction of<i>n</i>-Octanol/Water Partition Coefficients from PHYSPROP Database Using Artificial Neural Networks and E-State Indices
resolves10.1021/jm00106a030
Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure-activity relationships
resolves10.1161/01.HYP.17.3.270
Significance of vascular renin for local generation of angiotensins.
resolves10.1002/qsar.19950140405
A Rigorous Test for SPARC's Chemical Reactivity Models: Estimation of More Than 4300 Ionization pK<sub>a</sub>s
resolves10.2174/1573408052952702
Current Inhibition Concepts of Zinc Metallopeptidases Involved in Blood Pressure Regulation
resolves10.1007/s11224-005-6348-2
Theoretical Study of Gas-Phase Acidities of Selected Angiotensin-Converting Enzyme Inhibitors
resolves10.1007/s10822-005-8694-y
Virtual Computational Chemistry Laboratory – Design and Description
resolves10.1185/030079904X4185
Provision of cardiovascular protection by ACE inhibitors:a review of recent trials
resolves10.1016/j.drudis.2006.06.013
Can we estimate the accuracy of ADME–Tox predictions?
resolves10.1021/js980402t
Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood–brain barrier penetration
resolves10.1016/S0014-5793(98)01075-8
Enthalpy of captopril‐angiotensin I‐converting enzyme binding
resolves10.1016/S0140-6736(99)03190-6
Are drugs within a class interchangeable?
resolves10.1021/jm020017n
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
resolves10.1021/bi049480n
Structural Details on the Binding of Antihypertensive Drugs Captopril and Enalaprilat to Human Testicular Angiotensin I-Converting Enzyme <sup>,</sup>
resolves10.1016/j.bpc.2004.05.011
A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme
resolves10.2174/1568026013395100
Physicochemical Profiling (Solubility, Permeability and Charge State)
resolves10.2174/092986706775197917
In Silico Approaches to Prediction of Aqueous and DMSO Solubility of Drug-Like Compounds: Trends, Problems and Solutions
resolves10.1016/j.bmc.2004.07.049
Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides
resolves10.1016/S0169-409X(96)00423-1
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
resolves10.1002/med.10041
Selection criteria for drug‐like compounds
resolves10.1002/qsar.200330812
Prediction of the Vapor Pressure Boiling Point, Heat of Vaporization and Diffusion Coefficient of Organic Compounds
resolves10.1016/j.bmcl.2006.07.034
The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme
resolves10.1016/j.amjcard.2004.07.087
Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction
resolves10.1038/nature01370
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
resolves10.1080/0026897031000716583
Thermodynamics of binding of Zn<sup>2+</sup>to carbonic anhydrase inhibitors
resolves10.1023/A:1020444330011
Rate-Limited Steps of Human Oral Absorption and QSAR Studies
resolves10.1021/jm049661n
In Silico Prediction of Membrane Permeability from Calculated Molecular Parameters
resolves10.1016/0039-9140(95)01789-5
Estimation of the ionization p of pharmaceutical substances using the computer program
resolves10.1016/S0223-5234(02)01384-3
On the mechanism of human intestinal absorption
resolves10.1016/S0031-6997(24)01340-1
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
resolves10.1016/S0169-409X(03)00117-0
Prediction of physicochemical properties based on neural network modelling
resolves10.1016/S0378-5173(00)00564-0
A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors
resolves10.1097/00001721-200010000-00008
Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension
resolves10.1002/1521-3838(200010)19:4<366::AID-QSAR366>3.0.CO;2-E
Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico-chemical Parameters
resolves10.1016/j.amjhyper.2005.06.002
Renin-Angiotensin System Modulation: The Weight of Evidence
resolves10.1161/01.CIR.97.14.1411
Angiotensin-Converting Enzyme Inhibitors
resolves10.1021/jm0000564
QSAR Model for Drug Human Oral Bioavailability
resolves10.1023/A:1015823315983
Relative Lipophilicities and Structural-Pharmacological Considerations of Various Angiotensin-Converting Enzyme (ACE) Inhibitors
resolves10.1023/A:1020877402759
Current trends in lead discovery: Are we looking for the appropriate properties?
resolves10.1080/09537109877022
Effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril on endothelial and platelet functions in essential hypertension
resolves10.1021/ci049884m
ADME Evaluation in Drug Discovery. 5. Correlation of Caco-2 Permeation with Simple Molecular Properties
resolves10.1021/ci025515j
Application of Associative Neural Networks for Prediction of Lipophilicity in ALOGPS 2.1 Program
resolves10.2165/00003495-199040060-00004
Newer ACE Inhibitors
resolves10.1002/cmdc.200600155
Prediction of ADMET Properties
The 5 references without a DOI — listed, not checked
no DOI — not checkedin Burger s Chemistry and Drug Discovery th Therapeutic Agents New York
no DOI — not checked(reference deposited without a DOI or citation text)
no DOI — not checkedsuppl
no DOI — not checked(reference deposited without a DOI or citation text)
no DOI — not checkedAngiotensin Converting Enzyme Inhibitors nd New York
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.2478/s11696-007-0010-y"><img src="https://citestamp.com/citestamped/10.2478/s11696-007-0010-y/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.2478/s11696-007-0010-y/badge.svg)](https://citestamp.com/citestamped/10.2478/s11696-007-0010-y)